AMERICAS GOLD AND SILVER COR (USA.CA) Fundamental Analysis & Valuation

TSX:USA • CA03062D8035

Current stock price

7.26 CAD
+0.79 (+12.21%)
Last:

This USA.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. USA.CA Profitability Analysis

1.1 Basic Checks

  • In the past year USA has reported negative net income.
  • USA had a negative operating cash flow in the past year.
  • In the past 5 years USA always reported negative net income.
  • USA had a negative operating cash flow in each of the past 5 years.
USA.CA Yearly Net Income VS EBIT VS OCF VS FCFUSA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

  • USA's Return On Assets of -26.12% is in line compared to the rest of the industry. USA outperforms 47.17% of its industry peers.
  • USA's Return On Equity of -122.08% is on the low side compared to the rest of the industry. USA is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
ROA -26.12%
ROE -122.08%
ROIC N/A
ROA(3y)-21.76%
ROA(5y)-29.6%
ROE(3y)-67.54%
ROE(5y)-77.36%
ROIC(3y)N/A
ROIC(5y)N/A
USA.CA Yearly ROA, ROE, ROICUSA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • USA's Gross Margin of 18.54% is amongst the best of the industry. USA outperforms 87.42% of its industry peers.
  • In the last couple of years the Gross Margin of USA has grown nicely.
  • USA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y43.19%
USA.CA Yearly Profit, Operating, Gross MarginsUSA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1

2. USA.CA Health Analysis

2.1 Basic Checks

  • USA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, USA has more shares outstanding
  • Compared to 5 years ago, USA has more shares outstanding
  • USA has a better debt/assets ratio than last year.
USA.CA Yearly Shares OutstandingUSA.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
USA.CA Yearly Total Debt VS Total AssetsUSA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • USA has an Altman-Z score of 1.14. This is a bad value and indicates that USA is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.14, USA perfoms like the industry average, outperforming 42.14% of the companies in the same industry.
  • USA has a Debt/Equity ratio of 1.18. This is a high value indicating a heavy dependency on external financing.
  • USA has a Debt to Equity ratio of 1.18. This is in the lower half of the industry: USA underperforms 74.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF N/A
Altman-Z 1.14
ROIC/WACCN/A
WACC12.13%
USA.CA Yearly LT Debt VS Equity VS FCFUSA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 0.91 indicates that USA may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.91, USA is doing worse than 64.91% of the companies in the same industry.
  • USA has a Quick Ratio of 0.91. This is a bad value and indicates that USA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.77, USA is not doing good in the industry: 64.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.77
USA.CA Yearly Current Assets VS Current LiabilitesUSA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. USA.CA Growth Analysis

3.1 Past

  • USA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.67%, which is quite impressive.
  • USA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.36%.
  • Measured over the past years, USA shows a quite strong growth in Revenue. The Revenue has been growing by 11.40% on average per year.
EPS 1Y (TTM)36.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52%
Revenue 1Y (TTM)12.36%
Revenue growth 3Y30.77%
Revenue growth 5Y11.4%
Sales Q2Q%45.57%

3.2 Future

  • Based on estimates for the next years, USA will show a very strong growth in Earnings Per Share. The EPS will grow by 25.86% on average per year.
  • Based on estimates for the next years, USA will show a very strong growth in Revenue. The Revenue will grow by 31.10% on average per year.
EPS Next Y73.21%
EPS Next 2Y59.34%
EPS Next 3Y44.52%
EPS Next 5Y25.86%
Revenue Next Year15.88%
Revenue Next 2Y63.01%
Revenue Next 3Y51.93%
Revenue Next 5Y31.1%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
USA.CA Yearly Revenue VS EstimatesUSA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
USA.CA Yearly EPS VS EstimatesUSA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 -1 -1.5 -2

3

4. USA.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • USA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • USA is valuated rather expensively with a Price/Forward Earnings ratio of 21.48.
  • Based on the Price/Forward Earnings ratio, USA is valued cheaply inside the industry as 88.81% of the companies are valued more expensively.
  • USA's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.81.
Industry RankSector Rank
PE N/A
Fwd PE 21.48
USA.CA Price Earnings VS Forward Price EarningsUSA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USA.CA Per share dataUSA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as USA's earnings are expected to grow with 44.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.34%
EPS Next 3Y44.52%

0

5. USA.CA Dividend Analysis

5.1 Amount

  • No dividends for USA!.
Industry RankSector Rank
Dividend Yield 0%

USA.CA Fundamentals: All Metrics, Ratios and Statistics

AMERICAS GOLD AND SILVER COR

TSX:USA (3/31/2026, 7:00:00 PM)

7.26

+0.79 (+12.21%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-25
Earnings (Next)05-07
Inst Owners39.12%
Inst Owner ChangeN/A
Ins Owners5.04%
Ins Owner ChangeN/A
Market Cap1.99B
Revenue(TTM)109.13M
Net Income(TTM)-61.30M
Analysts80
Price Target12.66 (74.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-296.04%
Min EPS beat(2)-494.06%
Max EPS beat(2)-98.02%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.6%
Min Revenue beat(2)-22.37%
Max Revenue beat(2)-8.83%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)53.74%
PT rev (3m)78.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)17.79%
EPS NY rev (3m)14.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.48
P/S 13.06
P/FCF N/A
P/OCF N/A
P/B 28.39
P/tB 28.39
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)0.34
Fwd EY4.66%
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.56
BVpS0.26
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.12%
ROE -122.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.54%
FCFM N/A
ROA(3y)-21.76%
ROA(5y)-29.6%
ROE(3y)-67.54%
ROE(5y)-77.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y43.19%
F-Score2
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 160.68%
Cap/Sales 31.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.77
Altman-Z 1.14
F-Score2
WACC12.13%
ROIC/WACCN/A
Cap/Depr(3y)88.58%
Cap/Depr(5y)98.19%
Cap/Sales(3y)20.94%
Cap/Sales(5y)26.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52%
EPS Next Y73.21%
EPS Next 2Y59.34%
EPS Next 3Y44.52%
EPS Next 5Y25.86%
Revenue 1Y (TTM)12.36%
Revenue growth 3Y30.77%
Revenue growth 5Y11.4%
Sales Q2Q%45.57%
Revenue Next Year15.88%
Revenue Next 2Y63.01%
Revenue Next 3Y51.93%
Revenue Next 5Y31.1%
EBIT growth 1Y-61.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year201.82%
EBIT Next 3Y353.49%
EBIT Next 5Y155.12%
FCF growth 1Y-108.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-457.8%
OCF growth 3YN/A
OCF growth 5YN/A

AMERICAS GOLD AND SILVER COR / USA.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of AMERICAS GOLD AND SILVER COR (USA.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to USA.CA.


Can you provide the valuation status for AMERICAS GOLD AND SILVER COR?

ChartMill assigns a valuation rating of 3 / 10 to AMERICAS GOLD AND SILVER COR (USA.CA). This can be considered as Overvalued.


How profitable is AMERICAS GOLD AND SILVER COR (USA.CA) stock?

AMERICAS GOLD AND SILVER COR (USA.CA) has a profitability rating of 2 / 10.


How financially healthy is AMERICAS GOLD AND SILVER COR?

The financial health rating of AMERICAS GOLD AND SILVER COR (USA.CA) is 1 / 10.